School of Medicine
Showing 51-100 of 141 Results
-
Alesha Heath
Basic Life Research Scientist, Psych/Public Mental Health & Population Sciences
BioDr. Alesha Heath is a Postdoctoral Scholar at Psychiatry and Behavioral Sciences at Stanford School of Medicine and the MIRECC the VA Palo Alto. She earned her PhD from the University of Western Australia and Sorbonne University.
Dr. Heath's research has been primarily focused on the mechanisms and applications of brain stimulation therapies, in particular repetitive transcranial magnetic stimulation. Her research involves both basic and clinical components with the aim of improving the efficacy of these therapies for the treatment of disorders such as depression and Alzheimer's disease. -
Nuriya Ruth Hefron
Professional - NX, Psych/Public Mental Health & Population Sciences
Current Role at StanfordProgram Manager INSPIRE 360
Expansion of Early Psychosis Care Program -
Charlie Heriot-Maitland
Affiliate, Psych/Public Mental Health & Population Sciences
BioDr Heriot-Maitland is a clinical psychologist, trainer, researcher, and author. He is an international expert in Compassion Focused Therapy (CFT), and specifically the application of CFT for voice-hearing, trauma, and for people with psychosis and complex needs. Dr Heriot-Maitland is an experienced CFT therapist himself, and for the last 10 years has been leading the international development, research, and training of CFT for psychosis. His clinical research in this area has been mainly carried out at King’s College London and University of Glasgow, supported by funding from the UK Medical Research Council.
Dr Heriot-Maitland has published extensively on the theory and application of CFT in academic journals, produced videos and training materials, and has co-authored a self-help book on CFT for voice-hearers (Routledge, 2022). He has also developed novel and innovative interventions, based on CFT, for applications in different sectors (e.g., healthcare, social care, and education). Since 2012, he has been co-director of a UK organisation, Balanced Minds, which specialises in providing CFT therapy and resources for the general public and CFT training and supervision for professionals. He has been delivering training sessions at Stanford since 2019, and has held an Adjunct Lecturer appointment with the university since 2022. -
Keith Humphreys
Esther Ting Memorial Professor and Professor, by courtesy, of Health Policy
Current Research and Scholarly InterestsDr. Humphreys researches individual and societal level interventions for addictive and psychiatric disorders. He focuses particularly on evaluating the outcomes of professionally-administered treatments and peer-operated self-help groups (e.g., Alcoholics Anonymous), and, analyzing the impact of public policies touching addiction, mental health, public health, and public safety.
-
Alison Hwong
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioMy research focuses on improving health outcomes for people with mental illness, including: physical health and premature mortality for people with serious mental illness, aging and living with psychosis, social determinants of mental health, and the mental health effects of climate change.
-
Gabriella Imbriano
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioGabriella Imbriano, Ph.D. is the Co-Director for the Center for Mental Health Implementation Support (CMHIS) within the Stanford Center for Dissemination and Implementation and is a Clinical Assistant Professor within the Stanford School of Medicine. Dr. Imbriano is a clinical psychologist and research scientist. She is passionate about increasing access to evidenced-based mental health interventions and her previous work in the Veterans Health Administration, and in various university and academic medical centers, has inspired her commitment to science and practice integration. She has clinical expertise and research interests in traumatic stress disorders and trauma-informed care, women’s health care, and their intersections with implementation science.
-
Shaili Jain, MD
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Jain is a board certified psychiatrist with specialty expertise in posttraumatic stress disorder (PTSD), primary and mental health integrated care, and women’s health psychiatry. She is a former health services researcher, affiliated with the National Center for PTSD, who focuses on developing innovative ways to enhance the reach of mental healthcare in underserved populations with PTSD. Her work is widely accredited for elucidating the role of paraprofessionals and peers in the treatment of American veterans with PTSD.
She serves as the Psychiatry representative on Stanford's Executive Committee of the Association of Adjunct Clinical Faculty (AACF) and is also a council member for the Adjunct Clinical Faculty (ACF) council in Stanford's department of psychiatry. She is a distinguished fellow of the American Psychiatric Association.
Dr. Jain is an internationally recognized leader in communicating to the public about trauma and PTSD. Her posts for her Psychology Today blog on PTSD, In the Aftermath of Trauma, have been viewed over 350,000 times. Her acclaimed debut non-fiction trade book, The Unspeakable Mind: Stories of Trauma and Healing from the Frontlines of PTSD Science (Harper, 2019), was nominated for a National Book Award, and her essays and commentaries on trauma and PTSD have been presented by the BBC, CNN, The New York Times, STAT, Newsweek, The Los Angeles Times, The Washington Post, The Atlantic, USA Today, TEDx, public radio, and others -
Debra Lee Kaysen
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsMuch of my current research focus is on the development of testing of accessible, scaleable, and effective treatments for trauma-related disorders and related comorbidities (e.g. substance use disorders, HIV, mood disorders). This work has focused on addressing trauma-related disorders especially in underserved populations and settings. This includes research in rural communities, with Native American communities, and with sexual minorities. My research has had a strong impact on building an evidence base on adaptations of psychotherapies for PTSD and substance use disorders for diverse populations both within and outside the United States. Our findings demonstrate that complex cognitive behavioral psychotherapies like Cognitive Processing Therapy can be culturally adapted and delivered in challenging settings (conflict settings, high poverty environments) with significant and lasting change in PTSD, depression, and functioning. This has led to work adapting CPT for diverse populations within the United States (rural Native Americans, urban Latinos) and outside of it (Iraq, DRC). Other research has focused on treatment for PTSD/SUD. My research has also found support for the use of brief telehealth interventions to build treatment engagement and to reduce drinking among trauma-exposed populations. In addition, my work has been critical in testing the feasibility of novel trauma-focused interventions for use by those with PTSD and SUD, thus paving the road for more rigorous research studies.
Current PI'ed research studies include: 1) developing and evaluating a brief motivational interviewing intervention designed to increase treatment-seeking among military personnel with untreated PTSD; a two-arm randomized comparative effectiveness trial to evaluate prevention of HIV/STI sexual risk behavior by addressing PTSD through Narrative Exposure Therapy or substance use through Motivational Interviewing among Native American men and women with PTSD; and 3) a comparison of outcomes among patients randomized to initially receive pharmacotherapy or Written Exposure Therapy delivered in primary care as well as comparing outcomes among patients randomized to treatment sequences (i.e., switching and augmenting) for patients who do not respond to the initial treatment. -
Corey Keller, MD, PhD
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe goal of my lab is to understand the fundamental principles of human brain plasticity and build trans-diagnostic real-time monitoring platforms for personalized neurotherapeutics.
We use an array of neuroscience methods to better understand the basic principles of how to create change in brain circuits. We use this knowledge to develop more effective treatment strategies for depression and other psychiatric disorders. -
Christina Khan, MD, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Christina Khan is a pediatric and adult psychiatrist and Clinical Professor in the Department of Psychiatry and Behavioral Sciences. She specializes in the treatment of trauma, depression, anxiety, LGBTQ+ health, and physician wellness. Dr. Khan’s training includes doctoral and postdoctoral research training in community and public health, including specialized training in global health and PTSD research and treatment. Her work focuses on addressing health disparities in underserved populations and treating vulnerable and marginalized populations here in the United States and abroad.
At Stanford, she is co-Chief of the Diversity and Cultural Mental Health Section in the Department of Psychiatry and Behavioral Sciences and founder and Director of THRIVE, Stanford's LGBTQ+ mental health clinic. She has been working with WellConnect since 2014 addressing burnout, trauma, and secondary trauma in Stanford physicians. Dr. Khan is also a Faculty Fellow at the Center for Innovation in Global Health (CIGH) and serves on the CIGH Program Leadership Committee.
Nationally, Dr. Khan serves as Past President of the Association of Women Psychiatrists and as Councilor for the Council on Minority Mental Health and Health Disparities of the American Psychiatric Association. -
Jane P. Kim
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Kim’s research focuses on applying statistical approaches to evaluate and improve digital interventions, and using empirical approaches to understand ethical considerations for AI applications in healthcare.
-
Feng Vankee Lin
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health & Population Sciences)
Current Research and Scholarly InterestsMy career has been devoted to understanding the neural mechanisms involved in brain aging and brain plasticity, with a special focus on early detection and prevention of Alzheimer’s disease (AD). My research approach integrates principles and findings from cognitive theory, clinical neuroscience, and computational neuroscience.
-
Steven Lindley
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsMaximizing the use of evidence-based practices and reducing unnecessary medical burden of psychiatric treatments for stress-related disorders.
-
Michelle Madore, Ph.D.
Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psych/Public Mental Health & Population SciencesBioDr. Madore is multiracial, Filipina woman working as a Clinical Neuropsychologist at VA Palo Alto Healthcare System (VAPAHCS) in the Mental Illness Research, Education and Clinical Center (MIRECC). Here she serves as the Director of the National Clinical Transcranial Magnetic Stimulation (TMS) Program whose mission is to: 1) increase the availability of Transcranial Magnetic Stimulation (TMS) for treatment-resistant depression in Veterans and (2) gain a greater understanding of the treatment efficacy of TMS in our complex Veteran population. She is also the Co-Director of the Sierra Pacific MIRECC Advanced Fellowship at VAPAHCS. Dr. Madore is the Co-PI for studies looking at the clinical efficacy and safety for substance use disorders, specifically methamphetamine and alcohol. Dr. Madore is also a Clinical Associate Professor (Affiliated) at Stanford University School of Medicine’s Department in Psychiatry and Behavioral Sciences.
She received her Ph.D. in clinical psychology from the University of Cincinnati, where she received specialized training in neuropsychology. Dr. Madore completed her pre-doctoral internship at the VA Palo Alto Health Care System (VAPAHCS). She has completed postdoctoral training focused on clinical neuropsychology and neurorehabilitation research at VA Martinez, San Francisco VA Medical Center and VAPAHCS.
Dr. Madore is involved in several professional organizations and serves in several leadership positions. She is the Editor for the Asian American Journal of Psychology and Deputy Editor for Transcranial Magnetic Stimulation. -
Peter Manoleas
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioPeter Manoleas is a Licensed Clinical Social Worker with over 40 years’ experience in mental health and substance abuse as a clinician, administrator, and educator. He is emeritus faculty at the UC Berkeley, School of Social Welfare, having retired from the full time faculty in 2012. Manoleas has consulted widely, including to the (former) California Department of Mental Health, the (former) Mental Health Services Act Oversight and Accountability Commission, The California Endowment, and the UCSF Department of Psychiatry. He is the 2012 recipient of the California Wellness Foundation’s “Champion of Health Professions Diversity” award. He is on the editorial board of the Journal of Social Work Practice in the Addictions as well as a regular reviewer for Psychiatric Services, Manoleas has served on numerous boards and commissions, including the California Board of Behavioral Sciences on which he served from 2002-2006, the last year as Chair. He currently maintains a part-time practice.
-
Mark McGovern
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) and, by courtesy, of Pediatrics
BioDr. Mark McGovern is a Professor and the Associate Chair of Translation and Implementation Research in the Department of Psychiatry & Behavioral Sciences and, by courtesy, the Department of Medicine at Stanford University School of Medicine.
Most people who need health care do not receive it. And of those who do, wide variation exists in access to care and the quality of the care they receive in health care systems, both private and public. Dr. McGovern is a leader in using rigorous methods of implementation science to close these gaps in health care delivery.
His mission is to get the best health care possible to the people who need it the most.
Dr. McGovern's primary focus is the implementation and sustainment of evidence-based interventions and guideline adherent care in public and private health care systems and organizations. Within the hub of the Stanford Center for Dissemination and Implementation (CDI) which he directs, Dr. McGovern is the Principal Investigator (PI) and leads three national implementation research and practice centers: The Center for Dissemination and Implementation At Stanford (C-DIAS); The Research Adoption Support Center (RASC); and, the Mental Health Technology Transfer Center Network Coordinating Center (MHTTC). The 3 centers are federally-funded, respectively by the National Institute on Drug Abuse (P50DA05402), the National Institutes of Health Healing Addiction Long Term (HEAL) initiative (U2CDA057717), and the US Department of Health and Human Services Substance Use and Mental Health Services Administration (H79SM081726). Dr. McGovern is also the PI on a multi-site adaptive implementation trial across a state system of care, which aims to integrate addiction medications for persons with opioid use disorder who are receiving services in specialty or primary care organizations (R01DA052975). In addition, he addresses implementation challenges in federally-qualified health centers (FQHCs) across the State of California, in the Stanford Division of Primary Care and Population Health, and in specialty addiction and mental health treatment organizations nationwide. He leads, facilitates and/or actively engages networks advancing implementation science in health, including the NIDA Clinical Trials Network Translation & Implementation Special Interest Group, the NIDA Clinical Trials Western States Node Translation & Implementation Workgroup, the Stanford University Network for Dissemination & Implementation Research (SUNDIR), the VA Palo Alto HSR&D Center for Innovation to Implementation, and the Stanford Medicine Center for Improvement. He is on the Core Faculty of the National Institute of Mental Health Implementation Research Institute at the Washington University in St. Louis. Dr. McGovern is a collaborator on multiple projects as a co-investigator, consultant, or advisory board member. He is a mentor to numerous individuals across the country and at Stanford, from university undergraduates to mid-career faculty and clinical administrators at academic institutions and health care systems nationwide. -
Pavithra Mukunda
Clinical Rsch Mgr, Psych/Public Mental Health & Population Sciences
Current Role at StanfordClinical Research Manager
-
Martin Stefan Mumenthaler
Adjunct Professor, Psych/Public Mental Health & Population Sciences
BioMartin Mumenthaler has a PharmD and a PhD in psychopharmacology from the University of Bern, Switzerland. He holds an appointment as Adjunct Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has been conducting research programs in addiction medicine and psychopharmacology, and teaching and mentoring medical students and residents on a voluntary basis.
Dr. Mumenthaler has also been working in various full-time positions in the pharmaceutical industry as Director in Clinical Development as well as in Medical Affairs, and as a consultant for early-stage pharma- and biotech companies providing advice on designing and conducting clinical trials, and analyzing and interpreting study results, mainly in the field of addiction medicine and pain.
His academic research has focused on the effects of psychoactive drugs on human performance, Aerospace Medicine, Alzheimer’s disease, and addiction medicine, and in these areas he has presented his results internationally and published over twenty-five peer-reviewed scientific articles. He has also served as a reviewer for various scientific journals, and is a member of the Research Society on Alcoholism, and an Associate Fellow of the Aerospace Medical Association. -
Kalpana Isabel Nathan
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioKalpana Nathan, MD is an adjunct clinical professor, Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. After completion of residency and research fellowship at Stanford, she served 4 years at the San Francisco General Hospital/UCSF, gaining experience in the areas of substance use, HIV and public health. She worked at Palo Alto VA for more than a couple of decades. She served as chief medical director at Mental Health and Addiction services, El Camino Health for two and a half years, and later was the Executive Medical Director of Custody Behavioral Health at Santa Clara County. She is a certified physician executive. She has worked and taught in various settings, both inpatient and outpatient, as well as private and public sectors. She is board certified in General, Addiction and Forensic Psychiatry, as well as Lifestyle Medicine. Her interests include wellness and self-care for physicians, women's health, health creation and resiliency building for the community. She is a certified meditation teacher, has completed sprint and Olympic triathlons, and enjoys traveling around the world. She received the outstanding community clerkship preceptor award in 2010 and the Arthur L. Bloomfield Award in Recognition of Excellence in the Teaching of Clinical Medicine in 2015 at the Stanford University School of Medicine.
Recent Publications:
1. Yen Li, M, Mata C, Nathan K: Is Life Unlivable for Youth in Post-DEI America?: Understanding Rising Suicide Rates Across Diverse Youth Groups Through Traditional Suicide Paradigms. Healthcare 2025 Oct, 13(20), 2585 https://doi.org/10.3390/healthcare13202585
2. Tran BX, Nguyen TT, Boyer L, Fond G, Auquier P, Nguyen HSI,Ha Thi Nhi Tran HTN, Nguyen HM, Choi J, Le HT, Latkin CA, Nathan KI, Husain SF, et al: Differentiating people with schizophrenia from healthy controls in a developing country: An evaluation of portable functional near infrared spectroscopy (fNIRS) as an adjunct diagnostic tool. Frontiers of Psychiatry 2023 Jan 26; vol 14
3. Tatum, J, Nathan, K: The USA. Lancet Psychiatry 2021, 8(5):365-366
4. Nathan N & Nathan KI: Suicide, Stigma, and Utilizing Social Media Platforms to Gauge Public Perceptions. Front. Psychiatry 2020 January 13
5. Tran BX, Nathan KI, Phan HT, Hall BJ, Vu GT et al: A Global Bibliometric Analysis of Services for Children Affected by HIV/Acquired Immune Deficiency Syndrome: Implications for Impact Mitigation Programs (GAPRESEARCH). AIDS Rev. 2019 Oct 3;21(3).
6.Lee A, Nathan KI: Understanding Psychosis in a Veteran With a History of Combat and Multiple Sclerosis. Fed Pract. 2019 Jun;36(Suppl 4):S32-S35.
7. Tran BX, Ha GH, Vu GT, Nguyen LH, Latkin CA, Nathan K, McIntyre RS, Ho CS, Tam WW, Ho RC: Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis. Int J Environ Res Public Health. 2019 Jun 26;16(13) -
Ruth O'Hara
Director, Spectrum, Senior Associate Dean, Research and Lowell W. and Josephine Q. Berry Professor
Current Research and Scholarly InterestsDr. O'Hara's research aims to investigate how cognitive information processing deficits subserve affective symptoms in psychiatric disorders, and interact with key brain networks integral to these disorders. To do so, she has implemented a translational, interdisciplinary program that encompasses cellular models, brain and behavioral assays of affective and cognitive information processing systems in psychiatric disorders across the lifespan.
-
Karen Osilla
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsDr. Osilla conducts health services research with a focus on supporting families impacted by substance use. Dr. Osilla has been conducting addictions research since 2006 and has been involved in clinical trials evaluating cognitive behavioral therapy, collaborative care, and motivational interviewing interventions (web and in-person) among youth, adult, military, family members, and other hard-to-reach populations.
-
Michael Ostacher
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Ostacher is Professor of Psychiatry and Behavioral Sciences. He is the Site Director for the Addiction Medicine Fellowship at the VA Palo Alto Health Care System, where he also serves as the Medical Director of the Pharmacology of Addiction Recovery Clinic, the Director of the Bipolar and Depression Research Program and the Co-Director of the VA/Stanford Exploratory Therapeutics Lab, the Director of Advanced Fellowship Training in Mental Illness Research and Treatment for MDs for the VISN 21 MIRECC, and the Site Director at the VA Palo Alto for Advanced Fellowship Training for Stanford. A graduate of Vanderbilt University School of Medicine, the Harvard School of Public Health, and Harvard Medical School, he completed his training at The Cambridge Health Alliance at Harvard Medical School in Adult Psychiatry, Public Psychiatry, and Geriatric Psychiatry, and is currently board certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine. He is the Digital Content Editor for the journal Evidence-Based Mental Health and is on the editorial boards of Bipolar Disorders, the International Journal of Bipolar Disorders, the Journal of Clinical Psychiatry, Current Psychiatry, and Psychiatric Annals. His current research includes roles as Site Investigator for VA-BRAVE, multicenter, randomized trial comparing long-acting injectable buprenorphine to sublingual buprenorphine/naloxone, and trials of psychedelic drugs in psychiatric disorders in Veterans. With funding from NIDA, he studied, along with Jaimee Heffner, Ph.D. at the Fred Hutchinson Cancer Research Center in Seattle, smoking cessation in people with bipolar disorder using a novel online psychotherapy derived from Acceptance and Commitment Therapy. His primary research interest is in large clinical trials mental health and addiction, and the implementation of evidence-based mental health practices.
-
Ankita Patil
Research Assistant, Psych/Public Mental Health & Population Sciences
BioAnkita Patil is a public health researcher who passionately addresses health disparities through a social justice framework. With a BA in Social Psychology from The College of New Jersey, her research at Brigham & Women’s Hospital and Johns Hopkins tackles the health impacts of incarceration, trauma-informed care, and reproductive health challenges for incarcerated individuals. Her scholarly work contributed to policy reforms, including the co-authorship of an American Public Health Association policy statement which calls for the cessation of shackling incarcerated patients seeking medical care. Additionally, she has peer-reviewed a book focused on the impact of COVID-19 on Massachusetts’ prisons.
Beyond academia, Ankita has engaged deeply with community initiatives, working with organizations such as the Transformational Prison Project to bolster restorative justice and the Pandemic Response Network to meet the needs of communities most impacted by the pandemic. As a fervent advocate for health equity, Ankita’s career is characterized by a steadfast dedication to developing practical, empathetic solutions to increasingly complex public health challenges. This dedication will continue to evolve as she pursues an M.S. in Community Health and Prevention Research at Stanford, where she aims to further her impact on public health practices and policies.
